USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 4, Issue 10, Pages e867-e867
Publisher
Springer Nature
Online
2013-10-17
DOI
10.1038/cddis.2013.400
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy
- (2013) Yihui Fan et al. APOPTOSIS
- The genetic landscape of high-risk neuroblastoma
- (2013) Trevor J Pugh et al. NATURE GENETICS
- The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans
- (2012) V. Pant et al. BLOOD
- A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance
- (2012) Dharminder Chauhan et al. CANCER CELL
- Discovery of Specific Inhibitors of Human USP7/HAUSP Deubiquitinating Enzyme
- (2012) Céline Reverdy et al. CHEMISTRY & BIOLOGY
- Conformational stabilization of ubiquitin yields potent and selective inhibitors of USP7
- (2012) Yingnan Zhang et al. Nature Chemical Biology
- Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma
- (2011) Danielle M. Patterson et al. ANGIOGENESIS
- Activity-Based Chemical Proteomics Accelerates Inhibitor Development for Deubiquitylating Enzymes
- (2011) Mikael Altun et al. CHEMISTRY & BIOLOGY
- The p53 Pathway as a Target in Cancer Therapeutics: Obstacles and Promise
- (2011) A. Mandinova et al. Science Translational Medicine
- Immunology and immunotherapy of neuroblastoma
- (2011) Robert C. Seeger SEMINARS IN CANCER BIOLOGY
- Genetically engineered murine models – Contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastoma
- (2011) Louis Chesler et al. SEMINARS IN CANCER BIOLOGY
- Nutlin-3a Is a Potential Therapeutic for Ewing Sarcoma
- (2010) K. I. Pishas et al. CLINICAL CANCER RESEARCH
- The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor
- (2010) J. J. Manfredi GENES & DEVELOPMENT
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- p53 post-translational modification: deregulated in tumorigenesis
- (2010) Chao Dai et al. TRENDS IN MOLECULAR MEDICINE
- Reactivation of p53: from peptides to small molecules
- (2010) Christopher J. Brown et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Modes of p53 Regulation
- (2009) Jan-Philipp Kruse et al. CELL
- Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells
- (2009) F. Colland et al. MOLECULAR CANCER THERAPEUTICS
- Inactivation of HAUSP in vivo modulates p53 function
- (2009) N Kon et al. ONCOGENE
- Tumor Suppressive Functions of p53
- (2009) J. T. Zilfou et al. Cold Spring Harbor Perspectives in Biology
- Targeting ubiquitin specific proteases for drug discovery
- (2007) Laurent Daviet et al. BIOCHIMIE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started